Effect of perceptions of menstrual blood loss and menstrual pain on women’s quality of life

Author(s):  
Edith Weisberg ◽  
Kevin McGeehan ◽  
Ian S. Fraser
Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 4050-4050
Author(s):  
M. Kawaja ◽  
M.F. Scully ◽  
B. Barrett ◽  
M. Walsh ◽  
D. MacGregor

Abstract Iron deficiency is often used as a surrogate marker of bleeding. According to (multiple) studies, suboptimal iron stores can affect cognitive function, energy level and hence, quality of life. Due to a founder affect certain regions of the Canadian province of Newfoundland and Labrador have a very high prevalence of mild Hemophilia A. To accurately plan for future health related needs of these patients, a base-line cross-sectional study of a large cohort segregating a known founder mutation (Val2016Ala) was undertaken. Serum ferritin concentrations, complete blood counts (CBCs), menstrual blood loss assessed using Pictorial Blood Loss Assessment Chart (PBAC), bleeding histories, BMIs, and quality of life data using the SF-36 questionnaire were collected. Prevalence(%) of Suboptimal Iron Status for Women and Men Sub-Grouped By Menstrual Status and Mutation Status Serum Ferritin Cut-off(ug/L) **P Chi-Square <0.001 *P Chi-Square <0.01 Cohort <11 <24 <40 <50 Females(n=141) 12.1* 37.6** 55.3** 62.4** Males(n=77) 1.3* 4.1** 6.5** 6.5** Menstruating Women(n=81) 15.0 54.3** 71.6** 80.2** Non-Menstruating Women(n=58) 8.6 15.5** 31.0** 36.2** Menstruating Carriers(n=46) 8.7 50.0 65.2 73.9 Menstruating Controls(n=35) 23.5 60.0 80.0 88.6 Affected Males(n=46) 0.0 4.3 6.5 6.5 Control Males(n=31) 3.2 3.2 6.5 6.5 § Six women had hemoglobin concentrations less than 120 g/L and 11 men had concentrations less than 140 g/L, with anemia comparably observed in patients with or without the mutation(data not shown). Women in general reported a lower mean General Health Scale score (63.9, 59.9–67.9 vs. 70.6, 69.5–71.7) and a higher mean Role Emotional Scale score (89.3, 85.8–92.8 vs 79.5, 77.7–81.3) than norms for the general U.S. population. Men with a history of severe bleeding had significantly lower ferritin levels than men without a history of severe bleeding (123.4 g/L, 63.6–186.3 g/L, 105.9–301.5; p <0,05). Mutation status did not influence iron status in either sex or menstrual blood loss in women as measured by the PBAC. Serum ferritin level was not associated with PBAC score. Neither the means of the eight SF-36 domains, health transition scale, nor the two component summary measures were significantly lower for mildly iron-deficient or iron-deficient women. The SF-36 is a general measure of various quality of life domains and may not be sensitive enough to measure the effects iron deficiency could potentially have on women’s cognition and fatigue. A study using measures more sensitive to these affects would better investigate the impact of iron deficiency. Further research is also required to determine whether the low ferritin levels observed in women could possible be a result of inadequate dietary intake of iron or insufficient iron absorption in addition to menstrual blood loss.


2020 ◽  
Vol 29 (10) ◽  
pp. 1292-1302
Author(s):  
Joaquim Calaf ◽  
María Jesús Cancelo ◽  
Mercedes Andeyro ◽  
Juan Manuel Jiménez ◽  
Josep Perelló ◽  
...  

2012 ◽  
Vol 8 (5) ◽  
pp. 503-511 ◽  
Author(s):  
Andrea S Lukes ◽  
Jeffrey Baker ◽  
Scott Eder ◽  
Tammie L Adomako

Aim: Excessive blood loss during menstruation is a major problem for women of reproductive age. Women who experience heavy menstrual bleeding (HMB) often present to physicians because of the subsequent negative impact HMB has on their daily lives and activities. The objective of this post-hoc analysis is to evaluate daily menstrual blood loss (MBL) in women with HMB and assess the relationship between daily MBL and women's perceptions of MBL, limitations in physical activities and limitations in social/leisure activities as measured by the Menorrhagia Impact Questionnaire. Materials & methods: Data from two randomized, placebo-controlled studies of an oral tranexamic acid formulation in women with HMB were assessed. Daily MBLs and Menorrhagia Impact Questionnaire scores were evaluated for two pretreatment cycles and the first three tranexamic acid treatment cycles of each study. Effect-size analyses were not conducted. Results & conclusion: Highest daily MBLs occurred on days 2 and 3 of menstrual cycles. Women's perceptions of daily MBL were consistent with objective measures of MBL. Higher daily MBL was related to increased limitations in physical activities and limitations in social/leisure activities. Daily MBL values were consistent with women's perceptions of MBL. Reduced daily MBL was associated with improvements in health-related quality of life.


1961 ◽  
Vol 81 (4) ◽  
pp. 739-742 ◽  
Author(s):  
Richard M. Baldwin ◽  
P.J. Whalley ◽  
Jack A. Pritchard

Contraception ◽  
1972 ◽  
Vol 5 (6) ◽  
pp. 497-513 ◽  
Author(s):  
S.T. Shaw ◽  
D.E. Aaronson ◽  
D.L. Moyer

Contraception ◽  
1992 ◽  
Vol 46 (4) ◽  
pp. 327-334 ◽  
Author(s):  
Gerd Larsson ◽  
Lan Milsom ◽  
Göran Lindstedt ◽  
Göran Rybo

Sign in / Sign up

Export Citation Format

Share Document